Healthcare & Life Sciences
Oppilotech
United Kingdom
About
Develops novel antibiotics to address drug-resistant bacteria using a proprietary machine-learning platform for discovering and designing new antimicrobial compounds.
Explore Oppilotech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.